Table: begin end state 1 11 cytoplasmic 12 32 transmembrane 33 37 non-cytoplasmic 38 55 transmembrane 56 66 cytoplasmic 67 89 transmembrane 90 108 non-cytoplasmic 109 141 transmembrane 142 148 cytoplasmic 149 167 transmembrane 168 185 non-cytoplasmic 186 206 transmembrane 207 237 cytoplasmic 238 258 transmembrane 259 277 non-cytoplasmic 278 299 transmembrane 300 310 cytoplasmic 311 328 transmembrane 329 347 non-cytoplasmic 348 363 transmembrane 364 369 cytoplasmic 370 390 transmembrane 391 394 non-cytoplasmic 395 418 transmembrane 419 429 cytoplasmic 430 454 transmembrane 455 456 non-cytoplasmic
Input: >GFF658 FitnessBrowser__WCS417:GFF658 MELSTAVWMVHDTRLMFCVLLAIASIIVLISATKLPPFLSILIGTFIAGVGAGLPPEEVA KAFSKGAGAILGEAGIIIALGSMLGALMAESGAADRIATTLLGLGKGKALPWVMALVAMV IGLPLFFEVGLVMMVPIILVMAKRSNQPLLKIAIPALAGMTTLHALMPPHPGPLIAVSAL HADLGLTMLLGFCLAVPAVILAGPIYGNWLSKRLHVDEPADIGALFSAPPKAPRQPSFTV SLLIILLPVILMLGSTLAKVALPAESAIGLTLKFLGEPLIALGLAVVAAVICLGWAAGMP RAEVGNTLRKALAPIAVLLLTIGAGGGLKQTLLDAGVSQTISKVAEGAHMPYLLLAWLIA VALRQATGSATVATTTTAGILAPMMAGLAAPQSSLVALAIGAGSVFFCHVNDAGFWMVRE YFGLQLKQTIWVWSVLQTIVSVVGLVGTLLLWHFLT
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server